Literature DB >> 23394690

Association between QRS duration and outcome with cardiac resynchronization therapy: a systematic review and meta-analysis.

Adam R Bryant1, Stephen B Wilton, Michael P Lai, Derek V Exner.   

Abstract

PURPOSE: We conducted a systematic review and meta-analysis of randomized and observational studies to evaluate the associations between QRS duration (QRSd) at baseline or in follow-up and outcomes with cardiac resynchronization therapy (CRT).
METHODS: We searched online databases to December 2010 and included 6 randomized controlled trials (RCTs) and 38 observational studies. Outcomes included clinical/functional response, left ventricular (LV) remodeling, hospitalizations and mortality.
RESULTS: In RCTs, a benefit of CRT was evident only in patients with QRSd >150ms. In observational studies, those meeting either clinical or remodeling CRT response definitions had both wider pooled baseline QRSd and significantly more QRS narrowing with CRT than non-responders.
CONCLUSIONS: RCTs demonstrate that benefit with CRT appears restricted to those with baseline QRSd wider than 150ms. Both wider baseline QRS and more QRS narrowing are associated with CRT response in observational studies. Electrocardiographic QRSd plays an important role in CRT patient selection and follow-up.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23394690     DOI: 10.1016/j.jelectrocard.2012.12.003

Source DB:  PubMed          Journal:  J Electrocardiol        ISSN: 0022-0736            Impact factor:   1.438


  13 in total

1.  Wall Thickness, Pulmonary Hypertension, and Diastolic Filling Abnormalities Predict Response to Postoperative Biventricular Pacing.

Authors:  Robin M Brusen; Rebecca Hahn; Santos E Cabreriza; Bin Cheng; Daniel Y Wang; Wanda Truong; Henry M Spotnitz
Journal:  J Cardiothorac Vasc Anesth       Date:  2015-02-07       Impact factor: 2.628

2.  ICD lead type and RV lead position in CRT-D recipients.

Authors:  Alexander P Benz; Mate Vamos; Julia W Erath; Peter Bogyi; Gabor Z Duray; Stefan H Hohnloser
Journal:  Clin Res Cardiol       Date:  2018-05-24       Impact factor: 5.460

3.  Device therapy in heart failure with reduced ejection fraction-cardiac resynchronization therapy and more.

Authors:  D Duncker; C Veltmann
Journal:  Herz       Date:  2018-08       Impact factor: 1.443

4.  Precision Medicine for Cardiac Resynchronization: Predicting Quality of Life Benefits for Individual Patients-An Analysis From 5 Clinical Trials.

Authors:  Michael E Nassif; Yuanyuan Tang; John G Cleland; William T Abraham; Cecilia Linde; Michael R Gold; James B Young; J Claude Daubert; Lou Sherfesee; Dan Schaber; Anthony S L Tang; Philip G Jones; Suzanne V Arnold; John A Spertus
Journal:  Circ Heart Fail       Date:  2017-10       Impact factor: 8.790

5.  Impact of mechanical activation, scar, and electrical timing on cardiac resynchronization therapy response and clinical outcomes.

Authors:  Kenneth C Bilchick; Sujith Kuruvilla; Yasmin S Hamirani; Raghav Ramachandran; Samantha A Clarke; Katherine M Parker; George J Stukenborg; Pamela Mason; John D Ferguson; J Randall Moorman; Rohit Malhotra; J Michael Mangrum; Andrew E Darby; John Dimarco; Jeffrey W Holmes; Michael Salerno; Christopher M Kramer; Frederick H Epstein
Journal:  J Am Coll Cardiol       Date:  2014-03-05       Impact factor: 24.094

6.  Long-term outcome with cardiac resynchronization therapy in mild heart failure patients with left bundle branch block from US and Europe MADIT-CRT.

Authors:  Yitschak Biton; Valentina Kutyifa; Wojciech Zareba; Helmut U Klein; Scott D Solomon; Scott McNitt; Bronislava Polonsky; Arthur J Moss; Ilan Goldenberg
Journal:  Heart Fail Rev       Date:  2015-09       Impact factor: 4.214

7.  Association of QRS narrowing with response to cardiac resynchronization therapy-a systematic review and meta-analysis of observational studies.

Authors:  George Bazoukis; Katerina K Naka; Alawi Alsheikh-Ali; Gary Tse; Konstantinos P Letsas; Panagiotis Korantzopoulos; Tong Liu; Cynthia Yeung; Michael Efremidis; Konstantinos Tsioufis; Adrian Baranchuk; Stavros Stavrakis
Journal:  Heart Fail Rev       Date:  2020-09       Impact factor: 4.214

8.  Sex Differences in Long-Term Outcomes With Cardiac Resynchronization Therapy in Mild Heart Failure Patients With Left Bundle Branch Block.

Authors:  Yitschak Biton; Wojciech Zareba; Ilan Goldenberg; Helmut Klein; Scott McNitt; Bronislava Polonsky; Arthur J Moss; Valentina Kutyifa
Journal:  J Am Heart Assoc       Date:  2015-06-29       Impact factor: 5.501

Review 9.  Why QRS Duration Should Be Replaced by Better Measures of Electrical Activation to Improve Patient Selection for Cardiac Resynchronization Therapy.

Authors:  Elien B Engels; Masih Mafi-Rad; Antonius M W van Stipdonk; Kevin Vernooy; Frits W Prinzen
Journal:  J Cardiovasc Transl Res       Date:  2016-05-26       Impact factor: 4.132

10.  Patient-reported health status prior to cardiac resynchronisation therapy identifies patients at risk for poor survival and prolonged hospital stays.

Authors:  H Versteeg; J Denollet; M Meine; S S Pedersen
Journal:  Neth Heart J       Date:  2016-01       Impact factor: 2.380

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.